description
Glycerin
In our formula we are using 20% Azeclair, a solution containing 6% pure Potassium Azeloyl Diglycinate (PAD). While 6% might not sound like a high number, when it comes to PAD, it is an outstanding amount. The molecule is effective already and typically used at 1-3%. Studies done by the ingredient’s manufacturer show that 3% PAD (or 10% Azeclair) is an effective amount in normalizing oil production and evening the skin tone, while a study published in the Journal of Dermatological Treatment used 5% PAD for the management of rosacea.
Geek tip: Based on our experience, those who are sensitive to niacinamide tend to find aPAD an especially helpful addition to their skincare routine.
Who is it for?
how to use it?
Apply a few drops to the face after cleansing, before using emulsions and/or creams. Can be used either in the AM and/or PM.
Shelf life: 2 years from production (unopened), 6 months PAO (period after opening)
Ingredients & Research
key ingredients:
Potassium Azeloyl Diglycinate - A new generation azelaic acid derivative designed to be water-soluble and thus enable light formulas. It has a similar effect to the 3-in-1 clinical active azelaic acid that helps to normalize oil production, evening the skin tone, reducing blemishes, pigmentation and redness. There are a few studies using PAD already: two used it for the management of rosacea here and here, and another one used it for the management of melasma.
Allantoin - A classic skincare ingredient known for its skin soothing and skin protecting abilities.
Glycerin & Methyl-Gluceth 20 - A gentle humectant combination to help the skin to hold onto water.
full inci list:
Water, Potassium Azeloyl Diglycinate, Propanediol, Glycerin, Methyl-Gluceth 20, Allantoin, Hydroxyethylcellulose, Xanthan Gum, Citric Acid, Ethylhexylglycerin, Phenoxyethanol
research:
Berardesca, Enzo, et al. "Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea." Journal of cosmetic dermatology 11.1 (2012): 37-41.
Viyoch, Jarupa, et al. "Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study." Current Therapeutic Research 71.6 (2010): 345-359.
Veraldi, Stefano, et al. "Treatment of symptoms of erythemato-telangiectatic rosacea with topical potassium azeloyl diglycinate and hydroxypropyl chitosan: Results of a sponsor-free, multicenter, open study." Journal of Dermatological Treatment 26.2 (2015): 191-192.